30-Day morbidity after augmentation enterocystoplasty and appendicovesicostomy: A NSQIP pediatric analysis

In this cohort, any 30-day event is seen in almost 30% of the patients undergoing these urologic procedures. Operative time, number of concurrent procedures and higher surgical risk score all are associated with higher odds of the composite 30-day event of complication, readmission and/or reoperation. These data can be useful in counseling patients and families about expectations around surgery and in improving outcomes.Table. 30-day events by patient.Patients, n = 461Any NSQIP complications87 (18.9)UTI43 (9.3)Wound complications Superficial SSI19 (4.1) Deep SSI4 (0.9) Organ SSI5 (1.1) Dehiscence8 (1.7)Pneumonia1 (0.2)Reintubation1 (0.2)Bleeding/transfusion19 (4.1)Sepsis8 (1.7)Central line infection1 (0.2)Renal failure1 (0.2)Other 30-day outcomesReadmission62 (13.5)Reoperation32 (6.9)Composite 30-day event128 (27.8)Data given as n (%).